Merck

Effective April 1, 2024, Dhananjay Singh has taken over from Sreenath NS, who is retiring after 36 years of illustrious service…

The deal includes the novel HPN-217 and HPN-328 compounds, which are currently undergoing Phase II clinical trials for various…

KEYTRUDA is now approved for 14 indications across eight tumour types in India

V940-001 is the first phase 3 study of a planned comprehensive clinical development program being initiated following the positive…

Ten individuals will be awarded prizes totalling Rs 2,250,000

Skilled personnel, tech-transfer expertise, reliable supply chain, and regulatory guidelines critical to new technology adoption

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and…

Improvement in overall survival was one of the study's dual main goals, according to Merck and Eisai

Merck added that Sinopharm is the only legally authorised distributor of Merck's COVID-19 anti-viral molnupiravir in China

Molnupiravir, developed by Merck, is approved to be used in adult patients who have mild-to-medium COVID infection and a high risk…